Abstract
The first agents which could be used as intravenous anesthetics were barbiturates. Barbiturates with a duration of action appropriate to the requirements of surgery became available with the introduction of hexobarbital and thiopental (Volwiler and Tabern 1930; Miller et al. 1936). The studies with barbiturates were extended (Butler and Bush 1942; Christensen and Lee 1973). Intravenous anesthetics from other chemical groups were developed, such as acetamidoeugenol (Estil, Domenjoz 1959), steroid derivatives (Presuren = hydroxydione sodium, Laubach et al. 1955; alfaxolone, CT1341, Child et al. 1971), propanidid (Goidenthai 1971), ketamine (CI-581, Chen et al. 1966; Reich and Silvay 1989), etomidate (Janssen et al. 1975), propofol (ICI 35868, Glen 1980), and midazolam (Pieri 1983; Reilly and Nimmo 1987).
Similar content being viewed by others
References and Further Reading
Intravenous Anesthesia
Büch H, Butello W, Neurohr O, Rummel W (1968) Vergleich von Verteilung, narkotischer Wirksamkeit und metabolischer Elimination der optischen Antipoden von Methylphenobarbital. Biochem Pharmacol 17:2391–2398
Büch H, Grund W, Buzello W, Rummel W (1969) Narkotische Wirksamkeit und Gewebsverteilung der optischen Antipoden des Pentobarbitals bei der Ratte. Biochem Pharmacol 18:1005–1009
Butler TC, Bush MT (1942) Anesthetic potency of some new derivatives of barbituric acid. Proc Soc Exp Biol Med 50:232–243
Chen G, Ensor CR, Bohner B (1966) The Neuropharmacol of 2-(o-chlorophenyl)-2-methylaminocyclohexanone hydrochloride. J Pharmacol Exp Ther 152:332–339
Child KJ, Currie JP, Davis B, Dodds MG, Pearce DR, Twissell DJ (1971) The pharmacological properties in animals of CT1341 – a new steroid anaesthetic agent. Br J Anaesth 43:2–24
Christensen HD, Lee IS (1973) Anesthetic potency and acute toxicity of optically active disubstituted barbituric acids. Toxicol Appl Pharmacol 26:495–503
Domenjoz R (1959) Anaesthesist 8:16
Glen JB (1980) Animal studies of the anesthetic activity of ICI 35868. Br J Anaesth 52:731–742
Goldenthal EI (1971) A compilation of LD50 values in newborn and adult animals. Toxicol Appl Pharmacol 18:185–207
Janssen PAJ, Niemegeers CJE, Marsboom RPH (1975) Etomidate, a potent non-barbiturate hypnotic. Intravenous etomidate in mice, rats, guinea pigs, rabbits and dogs. Arch Int Pharmacodyn Ther 214:92–132
Laubach GD, Pan SY, Rudel HW (1955) Steroid anesthetic agent. Science 122:78
Miller E, Munch JC, Crossley FS, Hartung WH (1936) J Am Chem Soc 58:1090
Pieri L (1984) Preclinical pharmacology of midazolam. Br J Clin Pharmacol 16:17S–27S
Reich DL, Silvay G (1989) Ketamine: an update on the first twenty-five years of clinical experience. Can J Anaesth 36:186–197
Reilly CS, Nimmo WS (1987) New intravenous anaesthetics and neuromuscular blocking drugs. Drugs 34:98–135
Volwiler EH, Tabern DL (1930) J Am Chem Soc 52:1676
Screening of Intravenous Anesthetics
Büch H, Butello W, Neurohr O, Rummel W (1968) Vergleich von Verteilung, narkotischer Wirksamkeit und metabolischer Elimination der optischen Antipoden von Methylphenobarbital. Biochem Pharmacol 17:2391–2398
Chen G, Ensor CR, Bohner B (1966) The Neuropharmacol of 2-(o-chlorophenyl)-2-methylaminocyclohexanone hydrochloride. J Pharmacol Exp Ther 152:332–339
Child KJ, Currie JP, Davis B, Dodds MG, Pearce DR, Twissell DJ (1971) The pharmacological properties in animals of CT1341 – a new steroid anaesthetic agent. Br J Anaesth 43:2–24
Christensen HD, Lee IS (1973) Anesthetic potency and acute toxicity of optically active disubstituted barbituric acids. Toxicol Appl Pharmacol 26:495–503
Dingwall B, Reeve B, Hutchinson M, Smith PF, Darlington CL (1993) The tolerometer: a fast, automated method for the measurement of righting reflex latency in chronic drug studies. J Neurosci Methods 48:11–114
Glen JB (1977) A technique for the laboratory evaluation of the speed of onset of i.v. anesthesia. Br J Anaesth 49:545–549
Janssen PAJ, Niemegeers CJE, Marsboom RPH (1975) Etomidate, a potent non-barbiturate hypnotic. Intravenous etomidate in mice, rats, guinea pigs, rabbits and dogs. Arch Int Pharmacodyn Ther 214:92–132
Litchfield JT Jr, Wilcoxon FA (1949) Simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther 96:99–113
Michelsen LG, Salmenperä M, Hug CC, Sziam F, van der Meer D (1996) Anesthetic potency of remifentanil in dogs. Anesthesiology 84:865–872
Reilly CS, Nimmo WS (1987) New intravenous anaesthetics and neuromuscular blocking drugs. Drugs 34:98–135
Volwiler EH, Tabern DL (1930) 5,5-Substituted barbituric acids. J Am Chem Soc 52:1676–1679
EEG Threshold Test in Rats
Boiander HG, Wahlström G, Norberg L (1984) Reevaluation of potency and pharmacokinetic properties of some lipidsoluble barbiturates with an EEG-threshold method. Acta Pharmacol Toxicol 54:33–40
Korkmaz S, Wahlström G (1997) The EEG burst suppression threshold test for the determination of CNS sensitivity to intravenous anesthetics in rats. Brain Res Brain Res Protoc 1:378–384
Koskela T, Wahlström G (1989) Comparison of anaesthetic and kinetic properties of thiobutabarbital, butabarbital and hexobarbital after intravenous threshold doses in the male rat. Pharmacol Toxicol 64:308–313
Norberg L, Wahlström G (1988) Anaesthetic effects of flurazepam alone and in combination with thiopental or hexobarbital evaluated with an EEG-threshold method in male rats. Arch Int Pharmacodyn Ther 292:45–57
Norberg L, Wahlström G, Bäckström T (1987) The anaesthetic potency of 3α-hydroxy-5α-pregnan-20-one and 3αhydroxy-5β-pregnan-20-one determined with an intravenous EEG threshold method in male rats. Pharmacol Toxicol 61:42–47
Wauquier A, De Ryck M, Van den Broeck W, Van Loon J, Melis W, Janssen P (1988) Relationships between quantitative EEG measures and pharmacodynamics of alfentanil in dogs. Electroencephalogr Clin Neurophysiol 69:550–560
Efficacy and Safety of Intravenous Anesthetics
Borkowski GL, Dannemann PJ, Russel GB, Lang CM (1990) An evaluation of three intravenous regimens in New Zealand rabbits. Lab Anim Sci 40:270–276
Glen JB (1980) Animal studies of the anesthetic activity of ICI 35868. Br J Anaesth 52:731–742
Murdock HR (1969) Anesthesia in the rabbit. Fed Proc 28:1510–1516
Peeters ME, Gil D, Teske E, Eyzenbach V, vd Brom WE, Lumeij JT, de Vries HW (1988) Four methods for general anesthesia in rabbits: a comparative study. Lab Anim 22:355–360
Inhalation Anesthesia
Fang Z, Gong D, Ionescu P, Laster MJ, Eger EI II, Kendig J (1997) Maturation decreases ethanol minimum alveolar anesthetic concentration (MAC) more than desflurane MAC in rats. Anesth Analg 84:852–858
Robbins BH (1946) Preliminary studies of the anesthetic activity of fluorinated hydrocarbons. J Pharmacol Exp Ther 86:197–204
Wolfson B, Dorsch SE, Kuo TS, Siker ES (1972) Brain anesthetic concentration – a new concept. Anesthesiology 36:176–179
Screening of Volatile Anesthetics
Burgison RM (1964) Animal techniques for evaluating anesthetic drugs. In: Nodine JH, Siegler PE (eds) Animal and clinical techniques in drug evaluation. Year Book Medical Publishers, Chicago, pp 369–372
Burns THS, Hall JM, Bracken A, Gouldstone G (1961) Investigation of new fluorine compounds in anaesthesia (3): the anaesthetic properties of hexafluorobenzene. Anaesthesia 16:333–339
Ravento J, Spinks A (1958) Development of halothane. Methods of screening volatile anaesthetics. Manchester Univ Med School Gaz 37:55
RaventĂłs J (1956) Action of fluothane a new volatile anaesthetic. Br J Pharmacol 11:394
Van Poznak A, Artusio JF Jr (1960) Anesthetic compounds: II. Fluorinated ethers. Toxicol Appl Pharmacol 2:374
Determination of Minimal Alveolar Anesthetic Concentration (MAC)
Davis NL, Nunnally RL, Malinin TI (1975) Determination of the minimal alveolar concentration (MAC) of halothane in the white New Zealand rabbit. Br J Anaesth 47:341–345
Doquier MA, Lavand’homme P, Ledermann C, Collet V, de Kock M (2003) Can determining the minimum alveolar anesthetic concentration of volatile anesthetic be used as an objective tool to assess antinociception in animals? Anesth Analg 97:1033–1039
Eger EI II, Saidman LJ, Brandstater B (1965) Minimum alveolar anesthetic concentration: a standard of anesthetic potency. Anesthesiology 26:756–763
Eger EI II, Johnson BH, Weiskopf RB, Holmes MA, Yasuda N, Targ A, Rampil IJ (1988) Minimum alveolar concentration of I-653 and isoflurane in pigs. Anesth Analg 67:1174–1176
Eger EI II, Ionescu P, Laster MJ, Gong D, Hudlicky T, Kendig JJ, Harrius RA, Trudell JR, Pohorille A (1999) Maximum alveolar anesthetic concentration of fluorinated alkanols in rats: relevance to theories of narcosis. Anesth Analg 88:867–876
Eger EI II, **ng Y, Laster M, Sonner J, Antognini JF, Carstens E (2003) Halothane and isofluroane have additive minimum alveolar concentration (MAC) effects in rats. Anesth Analg 96:1350–1353
Fang Z, Gong D, Ionescu P, Laster MJ, Eger EI II, Kendig J (1997) Maturation decreases ethanol minimum alveolar anesthetic concentration (MAC) more than desflurane MAC in rats. Anesth Analg 84:852–858
Gong D, Fang Z, Ionescu P, Laster M, Terrell RC, Eger EI II (1998) Strain minimally influences anesthetic and convulsant requirements of inhaled compounds in rats. Anesth Analg 87:963–966, Eger EI II
Hall RI, Murphy MR, Hug CC (1987) The enfluorane sparing effect in dogs. Anesthesiology 67:518–525
Ide T, Sakurai Y, Aono M, Nishino T (1998) Minimum alveolar anesthetic concentrations for airway occlusion in cats: a new concept of minimum alveolar anesthetic concentration-airway occlusion response. Anesth Analg 86:191–197
Kashimoto S, Furuya A, Nonoka A, Oguchi T, Koshimizu M, Kumazawa T (1997) The minimum alveolar concentration of sevoflurane in rats. Eur J Anesth 14:359–361
Merkel G, Eger EI II (1963) A comparative study of halothane and halopropane anesthesia. Anesthesiology 24:346–357
Murphy MR, Hug CC (1982) The anesthetic potency of fentanyl in terms of its reduction of enflurane MAC. Anesthesiology 57:485–488
Quasha AL, Eger EI II, Tinker JH (1980) Determination and applications of MAC. Anesthesiology 53:315–334
Regan MJ, Eger EI II (1967) Effect of hypothermia in dogs on anesthetizing and apneic doses of inhalation agents. Determination of the anesthetic index (Apnea/MAC). Anesthesiology 28:689–700
Saidman LJ, Eger EI II (1964) Effect of nitrous oxide and narcotic premedication on the alveolar concentration of halothane required for anesthesia. Anesthesiology 25:302–306
Seifen E, Seifen AB, Kennedy RH, Bushman GA, Loss GE, Williams TG (1987) Comparison of cardiac effects of enflurane, isoflurane, and halothane in the dog heart-lung preparation. J Cardiothorac Anesth 1:543–553
Sonner JM (2002) Issues in the design and interpretation of minimum alveolar anesthetic concentration (MAC) studies. Anesth Analg 95:609–614
Waizer PR, Baez S, Orkin LR (1973) A method for determining minimum alveolar concentration of anesthetic in the rat. Anesthesiology 39:394–397
Efficacy and Safety of Inhalation Anesthetics
Antognini JF, Eisele PH (1993) Anesthetic potency and cardiopulmonary effects of enfluorane, halothane, and isofluorane in goats. Lab Anim Sci 43:607–610
Cervin A, Lindberg S (1998) Changes in mucociliary activity may be used to investigate the airway-irritating potency of volatile anaesthetics. Br J Anaesth 80:475–480
Chaves AA, Dech SJ, Nakayama T, Hamlin RL, Bauer JA, Carnes CA (2003) Age and anesthetic effects on murine electrocardiography. Life Sci 72:2401–2412
Fukuda H, Hirabayashi Y, Shimizu R, Saitoh K, Mitsuhata H (1996) Sevoflurane is equivalent to isoflurane for attenuating bupivacaine-induced arrhythmias and seizures in rats. Anesth Analg 83:570–573
Hanagata K, Matsukawa T, Sessler DI, Miyaji T, Funayama T, Koshimizu M, Kashimoto S, Kumazawa T (1995) Isoflurane and sevoflurane produce a dose-dependent reduction in the shivering threshold in rabbits. Anesth Analg 81:581–584
Hashimoto H, Imamura S, Ikeda K, Nakashima M (1994) Electrophysiological effects of volatile anesthetics, sevoflurane and halothane, in a canine myocardial infarction model. J Anesth 8:93–100
Hashimoto Y, Hirota K, Ohtomo N, Ishihara H, Matsuki A (1996) In vivo direct measurement of the bronchodilating effect of sevoflurane using a superfine fiberoptic bronchoscope: comparison with enflurane and halothane. J Cardiothorac Vasc Anesth 10:213–216
Hirano M, Fujigaki T, Shibata O, Sumikawa K (1995) A comparison of coronary hemodynamics during isoflurane and sevoflurane anesthesia in dogs. Anesth Analg 80:651–656
Hisaka Y, Ohe N, Takase K, Ogasawara S (1997) Cardiopulmonary effects of sevoflurane in cats: comparison with isoflurane, halothane, and enflurane. Res Vet Sci 63:205–210
Johnson RA, Striler E, Sawyer DC, Brunson DB (1998) Comparison of isoflurane with sevoflurane for anesthesia induction and recovery in adult dogs. Am J Vet Res 59:478–481
Kanaya N, Kawana S, Tsuchida H, Miyamoto A, Ohshika H, Namiki A (1998) Comparative myocardial depression of sevoflurane, isofluorane, and halothane in cultured neonatal rat ventricular myocytes. Anesth Analg 67:1041–1047
Kataoka Y, Manabe M, Takimoto E, Tokai H, Aono J, Hishiyama K, Ueda W (1994) Negative inotropic effects of sevoflurane, isoflurane, enflurane and halothane in canine blood-perfused papillary muscles. Anesth Resusc 30:73–76
Kissin I, Morgan PL, Smith LR (1983) Comparison of isoflurane and halothane safety margins in rats. Anesthesiology 58:556–561
Kissin I, Kerr CR, Smith LR (1984) Morphine-halothane interaction in rats. Anesthesiology 60:553–561
Krantz JC Jr, Carr CJ, Forman SE, Evans WE Jr, Wollenweber H (1941) Anesthesia. IV. The anesthetic action of cyclopropylethyl ether. J Pharmacol Exp Ther 72:233–244
Krantz JC Jr, Carr CJ, Lu G, Bell FK (1953) Anesthesia. XL. The anesthetic action of trifluoroethyl vinyl ether. J Pharmacol Exp Ther 108:488–495
Mazzeo AJ, Cheng EY, Bosnjak ZJ, Coon RL, Kampine JP (1996) Differential effects of desflurane and halothane on peripheral airway smooth muscle. Br J Anaesth 76:841–846
McMurphy RM, Hodgson DS (1996) Cardiopulmonary effects of desflurane in cats. Am J Vet Res 57:367–370
Mitsuhata H, Saitoh J, Shimizu R, Takeuchi H, Hasome N, Horiguchi Y (1994) Sevoflurane and isoflurane protect against bronchospasm in dogs. Anesthesiology 81:1230–1234
Mutoh T, Nishimura R, Kim HY, Matsunage S, Sasaki N (1997) Cardiopulmonary effects of sevoflurane, compared with halothane, enflurane, and isoflurane, in dogs. Am J Vet Res 58:885–890
Novalija E, Hogan QH, Kulier AH, Turner LH, Bosnjak ZJ (1998) Effects of desflurane, sevoflurane and halothane on postinfarction spontaneous dysrhythmias in dogs. Acta Anaesthesiol Scand 42:353–357
Saeki Y, Hasegawa Y, Shibamoto T, Yamaguchi Y, Hayashi T, Tanaka S, Wang GH, Koyama S (1996) The effects of sevoflurane, enflurane, and isoflurane on baroreceptor-sympathetic reflex in rabbits. Anesth Analg 82:342–348
Salmempera M, Wilson D, Szlam F, Hugg CC Jr (1992) Anesthetic potency of the opioid GI 87084B in dogs. Anesthesiology 77:A368
Soma LR, Terney WJ, Hogan GK, Satoh N (1995) The effects of multiple administrations of sevoflurane to cynomolgus monkeys: clinical pathologic, hematologic and pathologic study. Anesth Analg 81:347–352
Steffey EP, Howland D (1978) Potency of enflurane in dogs: comparison with halothane and isoflurane. Am J Vet Res 39:573–577
Van Poznak A, Artusio F Jr (1960a) Anesthetic properties of a series of fluorinated compounds. I. Fluorinated hydrocarbons. Toxicol Appl Pharmacol 2:363–373
Van Poznak A, Artusio F Jr (1960b) Anesthetic properties of a series of fluorinated compounds. II. Fluorinated ethers. Toxicol Appl Pharmacol 2:363–373
White PF, Johnston RR, Eger EI II (1974) Determination of anesthetic requirement in rats. Anesthesiology 40:52–57
Wolfson B, Kielar CM, Lake C, Hetrick WD, Siker ES (1973) Anesthetic index a new approach. Anesthesiology 38:583–586
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Berlin Heidelberg
About this entry
Cite this entry
Kallman, M.J. (2015). General Anesthetics. In: Hock, F. (eds) Drug Discovery and Evaluation: Pharmacological Assays. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-27728-3_34-1
Download citation
DOI: https://doi.org/10.1007/978-3-642-27728-3_34-1
Received:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Online ISBN: 978-3-642-27728-3
eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences